i2.JP is currently recruiting ideas from individuals and teams who are interested in tackling the following themes. If you are interested, please check the outline and eligibility before sending in your application. We are looking forward to hearing from you. Please feel free to contact us if you have any questions about Challenge Application.

early detection for CKD

Early diagnosis for CKD

We are seeking for innovative healthcare products or services to support early diagnosis of CKD. Desired solutions will quantitatively assess risks and support active CKD diagnosis by primary care providers.

Partners
AstraZeneca
Status
Currently accepting(Due:2022.8.31)

Please contact us the below inquiry form

early intervention for COPD

Early intervention for COPD

Chronic obstructive pulmonary disease (COPD) is one of the diseases, where we still see a high number of undiagnosed patients. We are seeking for ideas that may help potential patients recognize that they have COPD and start treatment with a specialist, preferably by direct activation of potential COPD patients with traceability function to confirm their visit to a specialist.

Partners
AstraZeneca
Status
Currently accepting(Due:2022.8.31)

Please contact us the below inquiry form

remote home care after treatment

Remote home care after treatment

We are seeking for innovative remote home care monitoring tools or services to evaluate patient conditions after treatment. Desired solutions will need to be user-friendly for the elderly in home care setting, with highly accurate sensing technologies.

Partners
AstraZeneca
Status
Currently accepting(Due:2022.8.31)

Please contact us the below inquiry form

Closed Challenge Applications

Utilisation of digital biomarkers and digital therapeutics that can improve patient-centric outcomes in heart failure and renal disease

Utilisation of digital biomarkers and digital therapeutics that can improve patient-centric outcomes in heart failure and renal disease

We are seeking innovative solutions accelerating innovative science.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Innovations in delivery of new modalities; peptides, oligos and antibodies across oncology, cardiovascular, renal and respiratory diseases

Innovations in delivery of new modalities; peptides, oligos and antibodies across oncology, cardiovascular, renal and respiratory diseases

We are seeking innovative solutions accelerating innovative science.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Identify sources of biological samples from diverse genetic backgrounds to enhance disease understanding

Generating multi-omics data in specific patient cohorts including NASH, rare cardiovascular diseases and immunological conditions

We are seeking innovative solutions accelerating innovative science.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Identify sources of biological samples from diverse genetic backgrounds to enhance disease understanding

Identify sources of biological samples from diverse genetic backgrounds to enhance disease understanding

We are seeking innovative solutions accelerating innovative science.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Support the development of Regulatory T cell therapy for treatment of immune-mediated diseases

Support the development of Regulatory T cell therapy for treatment of immune-mediated diseases

We are seeking innovative solutions accelerating innovative science.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Activate multidisciplinary teams to deliver optimal outcomes for cancer patients

Activate multidisciplinary teams to deliver optimal outcomes for cancer patients

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Scale up integrated oncology patient care management platforms

Scale up integrated oncology patient care management platforms

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Improve early detection of lung cancer

Improve early detection of lung cancer

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Drive systemic lupus erythematosus awareness and early patient identification

Drive systemic lupus erythematosus awareness and early patient identification

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Transform severe asthma care and treatment

Transform severe asthma care and treatment

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Improve early diagnosis of chronic kidney disease

Improve early diagnosis of chronic kidney disease

We are seeking innovative solutions delivering growth and therapy area leadership.

Partners
AstraZeneca A.Catalyst Network
Status
Application deadline
Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

AION Labs, Powered by BioMed X, Launches Second Global Call for Application:Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

Partners
AION Labs, BioMed X
Status
Application deadline
Novel molecular insights into metabolic disease

Novel molecular insights into metabolic disease

We are seeking collaborators with novel molecular insight into the pathogenesis of metabolic disease that reverses hepatic, cardiovascular and/or renal complications.

Partners
AstraZeneca
Status
Application deadline
Gut microbiome modification to influence renal dysfunction

Gut microbiome modification to influence renal dysfunction

We are seeking novel methods that can modify the microbiome or its products to treat or prevent renal diseases. These may include (but are not limited to) clinical samples from interesting patient populations or innovative technologies and potential therapies.

Partners
AstraZeneca
Status
Application deadline
Molecular strategies to minimiseoff-target toxicities of antibody-drug conjugates (ADCs)

Molecular strategies to minimiseoff-target toxicities of antibody-drug conjugates (ADCs)

We are seeking proposals that may address the following areas: uptake in normal tissue, off target toxicity, delivery.

Partners
AstraZeneca
Status
Application deadline
Innovative vaccine technologies to enable the development of a universal HRV vaccine

Innovative vaccine technologies to enable the development of a universal HRV vaccine

We are seeking an innovative vaccine technology and/or antigen display approach that elicits a potent, broad and durable immune response to enable a universal HRV vaccine.

Partners
AstraZeneca
Status
Application deadline
Novel solutions for the non-invasive detection and monitoring of NASH

Novel solutions for the non-invasive detection and monitoring of NASH

We are seeking novel solutions that enable the non-invasive diagnosis and monitoring of NASH disease progression/regression. The ideal solution would deliver impact in the near-medium term.

Partners
AstraZeneca
Status
Application deadline
Revitalizing Saga Prefecture through Beauty and Healthcare Investments

Revitalizing Saga Prefecture through Beauty and Healthcare Investments

We are looking for domestic and foreign start-ups that aim to develop innovative products/services, under the three themes “Cosmetics”, “Beauty Devices/Services”, and “Healthcare”, that will revitalize Saga Prefecture, one of Asia’s leading beauty and healthcare industry clusters.

Partners
Saga Prefecture
Agorize Japan
Vertex Partners
Status
Application deadline

For inquiries

Interested in joining us?

Please confirm the Privacy Policy before sending your inquiry

Thank you for your interest. We will get in touch soon.